LB Pharmaceuticals Market Sentiment

LB Pharmaceuticals Inc

LBRXNASDAQ

$39.64

N/A

Last update: Oct 27, 4:00 PM

Market sentiment signals for LB Pharmaceuticals (LBRX): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 21.9% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

$54

+36.5%

Highest Price Target

$80

+101.8%

Guggenheim

Lowest Price Target

$34

-14.2%

Leerink Partners

Short Interest

21.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 9, 2026	Canaccord Genuity	Sumant Kulkarni—	+64.0%	$65	Initiate	Buy
Oct 6, 2026	Guggenheim	Delma Caiati—	+101.8%	$80	Initiate	Buy
Oct 5, 2026	Roth Capital	Boobalan Pachaiyappan—	-11.7%	$37 → $35	Downgrade	Buy→Neutral
Oct 2, 2026	Needham	Ami Fadia—	+71.5%	$68	Initiate	Buy
Aug 24, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+51.4%	$45 → $60	Maintained	Buy
Aug 12, 2026	BMO Capital	Malcolm Hoffman—	+36.2%	$46 → $54	Maintained	Outperform
Aug 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+13.5%	$45 → $45	Maintained	Buy
Jul 21, 2026	BMO Capital	Malcolm Hoffman—	+16.0%	$46	Initiate	Outperform
Jul 7, 2026	Wolfe Research	Rudy Li—	+13.5%	$45	Initiate	Outperform
Apr 27, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+13.5%	$45	Initiate	Buy
Apr 10, 2026	Craig-Hallum	Adam Vogel—	-9.2%	$36	Initiate	Buy
Mar 27, 2026	Stifel	Paul Matteis—	+0.9%	$35 → $40	Maintained	Buy
Dec 11, 2025	Stifel	Paul Matteis—	-11.7%	$27 → $35	Maintained	Buy
Oct 6, 2025	Piper Sandler	Yasmeen Rahimi—	+96.8%	$78	Initiate	Overweight
Oct 6, 2025	Stifel	Paul Matteis—	-31.9%	$27	Initiate	Buy
Oct 6, 2025	Leerink Partners	Marc Goodman—	-14.2%	$34	Initiate	Outperform